GNFT
Genfit S.A.
NASDAQ · Healthcare · Biotechnology · FR
$8.95
+4.07%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.30x
- Price / sales
- 3.28x
- Price / cash flow
- -8.57x
Enterprise value
- Enterprise value
- $482.0M
- EV / sales
- 3.55x
- EV / EBITDA
- -295.97x
- EV / EBIT
- 802.05x
- Market cap
- $445.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2025